Helicobacter pylori vacA, iceA, and cagA status and pattern of gastritis in patients with malignant and benign gastroduodenal disease

American Journal of Gastroenterology

Volumn 96, Issue 4, 2001, Pages 1008-1013

  Miehlke, Stephan ^a   Yu, Jun ^b   Schuppler, Markus ^b   Frings, Christian ^b   Kirsch, Christian ^b   Negraszus, Nico ^b   Morgner, Andrea ^b   Stolte, Manfred ^b   Ehninger, Gerhard ^b   Bayerdörffer, Ekkehard ^b  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b INSTITUTE OF PATHOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CAGA PROTEIN; PROTEIN ICEA; UNCLASSIFIED DRUG; VACUOLATING TOXIN; VIRULENCE FACTOR;

ADULT; AGED; ARTICLE; BENIGN TUMOR; CANCER RISK; DISEASE COURSE; DUODENUM CANCER; DYSPEPSIA; FEMALE; GASTRITIS; GENE FREQUENCY; GENOTYPE; GERMANY; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCORING SYSTEM; STOMACH BIOPSY; STOMACH CANCER; STOMACH LYMPHOMA;

AGED; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; DUODENAL ULCER; DYSPEPSIA; FEMALE; GASTRITIS; GENOTYPE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE; MALE; STOMACH NEOPLASMS;

EID: 0035048621     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(01)02248-1     Document Type: Article

References (45)

1. Helicobacter pylori and peptic ulcer
2. Helicobacter pylori infection and the risk of gastric carcinoma
3. Association between infection with Helicobacter pylori and risk of gastric cancer: Evidence from a prospective investigation
4. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma
5. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection
6. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer
7. Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolating cyctotoxin activity
8. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach
9. Helicobacter pylori and atrophic gastritis: Importance of the cagA status
10. Cag, a pathogenicity island of Helicobacter pylori encodes type I-specific, and disease-associated virulence factors
11. Altered states: Involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori
12. Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells
13. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion
14. Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation
15. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori
16. Expanding allelic diversity of Helicobacter pylori vacA
17. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori
18. Adherence to gastric epithelial cells induces expression of a Helicobacter pylori gene, iceA, that is associated with clinical outcome
19. Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori
20. Natural history of gastritis and its relationship to peptic ulcer disease
21. How does Helicobacter pylori cause mucosal damage? Its effect on acid and gastric physiology
22. Differing degree and distribution of gastritis in Helicobacter pylori associated diseases
23. Severe expression of corpus gastritis is characteristic in gastric cancer patients infected with Helicobacter pylori
24. Classification and grading of gastritis: The updated Sydney System
25. PCR amplification of gene sequences from Helicobacter pylori strains
26. Allelic variation in Helicobacter pylori cagA gene from Korea compared to the United States
27. Geographic distribution of vacA allelic types of Helicobacter pylori
28. Relationship betwen Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: Studies in four different countries
29. Heterogeneity in the Helicobacter pylori vacA and cagA genes: Association with gastroduodenal disease in South Africa?
30. Diversity of Helicobacter pylori vacA and cagA genes and relationship to VacA and CagA protein expression, cytotoxin production, and associated diseases
31. Analysis of Helicobacter pylori vacA and cagA genotypes and serum antibody profile in benign and malignant gastroduodenal disease
32. Major virulence factors, VacA and CagA, are commonly positive in Helicobacter pylori isolates in Japan
33. Vacuolating toxin production in clinical isolates of Helicobacter pylori with different vacA genotypes
34. Evaluation of Helicobacter pylori vacA genotypes in Japanese patients with gastric cancer
35. Analysis and typing of the vacA gene from cagA-positive strains of Helicobacter pylori isolated in Japan
36. Failure to confirm association of the vacA gene mosaicism with duodenal ulcer disease
37. Evaluation of the clinical relevance of the iceA1 gene in patients with Helicobacter pylori infection
38. What are the host factors that place an individual at risk for Helicobacter pylori associated disease?
39. The role of the HLA-DQA 1 gene in resistance to atrophic gastritis and gastric adenocarcinoma induced by Helicobacter pylori infection
40. The risk of stomach cancer in patients with gastric or duodenal ulcer disease
41. Clinical impact of routine biopsies of the gastric antrum and body
42. Helicobacter pylori gastritis of the gastric cancer phenotype in relatives of gastric carcinoma patients
43. Increased prevalence of precancerous changes in relatives of gastric cancer patients: Critical role of H. pylori
44. Interleukin-1 polymorphisms associated with increased risk of gastric cancer
45. Gastric carcinoma risk index in patients infected with Helicobacter pylori